Join
Live feed
·
INSIDERFilingvia Quantisnow
Lineage Cell Therapeutics Inc. logo

Director Broadwood Partners, L.P. bought $6,000,000 worth of shares (7,894,737 units at $0.76) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LCTX· Lineage Cell Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LCTX (Lineage Cell Therapeutics Inc.) and more on Quantisnow.